BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21180027)

  • 1. Bisoprolol and heart failure: new frontiers.
    Chopra HK
    Indian Heart J; 2010; 62(1):7-12. PubMed ID: 21180027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
    Wikstrand J; Wedel H; Castagno D; McMurray JJ
    J Intern Med; 2014 Feb; 275(2):134-43. PubMed ID: 24118421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy of chronic heart failure: when are beta receptor blockers indicated?].
    vom Dahl J; Schotten U; Sasse A
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S48-53. PubMed ID: 10535047
    [No Abstract]   [Full Text] [Related]  

  • 5. Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results.
    Metra M; Nodari S; Bordonali T; Milani P; Lombardi C; Bugatti S; Fontanella B; Verzura G; Danesi R; Dei Cas L
    Ther Clin Risk Manag; 2007 Aug; 3(4):569-78. PubMed ID: 18472978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
    Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
    Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistency of ss-blocker effect across various subgroups with heart failure: insights from the MERIT-HF trial.
    Wikstrand J; Ghali JK; Goldstein S
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):16-23. PubMed ID: 19667604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blockers in heart failure: how far have we progressed?
    Adams KF
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):7-15. PubMed ID: 19667603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of beta-blockers in congestive heart failure.
    Sallach JA; Goldstein S
    Ann Med; 2003; 35(4):259-66. PubMed ID: 12846268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of beta-blockers for heart failure in patients with diabetes mellitus.
    Giles TD
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):32-7. PubMed ID: 19667606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].
    MMW Fortschr Med; 2003 Jul; 145(27-28):60. PubMed ID: 14587195
    [No Abstract]   [Full Text] [Related]  

  • 12. [Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
    Sinagra G; Boccanelli A; Camerini F; Gavazzi A; Gronda E; Maggioni AP; Opasich C; Rapezzi C; Scherillo M; Tavazzi L
    G Ital Cardiol; 1998 Jan; 28(1):61-70. PubMed ID: 9493048
    [No Abstract]   [Full Text] [Related]  

  • 13. Determinants of change in quality of life in the Cardiac Insufficiency Bisoprolol Study in Elderly (CIBIS-ELD).
    Scherer M; Düngen HD; Inkrot S; Tahirović E; Lashki DJ; Apostolović S; Edelmann F; Wachter R; Loncar G; Haverkamp W; Neskovic A; Herrmann-Lingen C
    Eur J Intern Med; 2013 Jun; 24(4):333-8. PubMed ID: 23375618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
    Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
    Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers and heart failure.
    Cruickshank JM
    Indian Heart J; 2010; 62(2):101-10. PubMed ID: 21180298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
    Fowler MB
    Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
    Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
    Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta blockers for therapy of chronic heart failure].
    Murakami T
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):248-54. PubMed ID: 15768588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.